 |
 |
 |
|
Long-Term B/F/TAF Switch Efficacy in Patients
with Archived Pre-Existing Resistance?
|
|
|
Reported by Jules Levin
CROI 2019 March 4-7 Seattle
Kristen Andreatta, Madeleine Willkom, Ross Martin, Silvia Chang, Hui Liu, Ya-Pei Liu, Hiba Graham, Hal Martin, and Kirsten L. White
Gilead Sciences, Inc., Foster City, CA, USA






|
|
|
 |
 |
|
|